The global research antibodies market is on track for steady growth, with a projected value of USD 2.4 billion by 2030. This translates to a compound annual growth rate (CAGR) of 4.9% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 1.7 billion in 2022.
The global transfer membrane market is anticipated to witness steady growth, reaching an estimated value of USD 552.0 million by 2030. This translates to a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 385.2 million in 2022.
personalized nutrition market reflects this trend. This market, estimated at USD 11.4 billion in 2022, is projected to reach a staggering USD 36.8 billion by 2030, according to a recent market analysis. This translates to a significant compound annual growth rate (CAGR) of 15.8% during the forecast period of 2023-2030.
The global protein engineering market is poised for a transformative journey, with a projected value of USD 7.5 billion by 2030. This translates to a remarkable compound annual growth rate (CAGR) of 16.7% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 2.2 billion in 2022.
The global breastfeeding accessories market is on track for significant growth, with a projected value of USD 3.9 billion by 2030. This translates to a steady compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 2.4 billion in 2022.
Key Players
The major key players are Medela AG, Ameda, Inc., Willow Innovations, Inc., Koninklijke Philips N.V., Mitera LLC, Elvie (Chiaro Technology), Freemie, Spectra Baby, iAPOY, Lavie Mom, Pigeon. Motif Medical, and Others.
The global neonatal critical care equipment market is on track for a promising trajectory, with a projected value of USD 5.03 billion by 2030. This translates to a steady compound annual growth rate (CAGR) of 7.6% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 2.8 billion in 2022.
The global cell freezing media market is poised for significant growth, with a projected value of USD 296.3 million by 2030. This translates to a healthy compound annual growth rate (CAGR) of 9.7% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 141.3 million in 2022.
The global polyclonal antibodies market is anticipated to witness steady growth, reaching an estimated value of USD 2.5 billion by 2030. This translates to a compound annual growth rate (CAGR) of 5.1% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 1.7 billion in 2022.
The global cancer biomarker Market is on track for a promising trajectory, with a projected value of USD 27.4 billion by 2030. This translates to a significant compound annual growth rate (CAGR) of 12.0% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 11.1 billion in 2022.
The global glycomics market is on a trajectory for remarkable expansion, with a projected value of USD 5.09 billion by 2030. This translates to a staggering compound annual growth rate (CAGR) of 14.7% during the forecast period of 2023-2030, according to a recent market analysis. The market size was estimated at USD 1.7 billion in 2022.
